Skip to main content
Premium Trial:

Request an Annual Quote

European Court Sides With Oxford Gene Technology in Patent Dispute

NEW YORK, Nov. 23 - The European Patent Office has sided with Oxford Gene Technology after a six-year patent dispute the chip company filed against a number of microarray, biotech, and pharmaceutical firms, OGT said on Friday.


Seven companies, including Affymetrix, Abbott Laboratories, Roche Holding, and Nanogen, originally opposed the patent, which was granted to OGT by the EPO in 1994. Affy withdrew after settling with ODG in March.


Ed Southern, owner of UK-based OGT and the patent's inventor, said the decision "greatly strengthens the patent, and we intend to pursue the many licensing opportunities with renewed determination."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.